Amphetamine

Safety Summary

Regulatory Status

Sources

These citations are the ones recorded for the human adult context.

• US DEA: Amphetamine — Schedule II Classification, ADHD/Narcolepsy FDA Approvals, Mixed Amphetamine Salts (Adderall), Lisdexamfetamine (Vyvanse) Prodrug, Diversion and Misuse, and College Campus Nonmedical Use Prevalence (2022) REGULATORY · 2022
• US FDA: Mixed Amphetamine Salts (Adderall/Adderall XR) — Prescribing Information, Pediatric Growth Effects, Cardiovascular Screening, Overdose Toxidrome Management, and ADHD Efficacy Data (2022) REGULATORY · 2022
• identity database ECHA CHEM, Download all substances: REACH registrations (ECHA's own list of REACH-registered substances) REGULATORY · 2026
• where to look PubChem: Toxicity section (CID 3007) PUBCHEM
• OEHHA Proposition 65 List of Carcinogens or Reproductive Toxicants (CSV, list date 31-Jul-26) REGULATORY
• Permissible Exposure Limits – OSHA Annotated Table Z-1 REGULATORY
• where to look CAMEO Chemicals, as recorded by PubChem (Experimental Properties, CID 3007; where-to-look, not a source of this value) DATABASE · 2026
• EPA CompTox CTX API: predicted properties for DTXSID4022600 (Amphetamine) REFERENCE

Same data as the API response, which is open and needs no key. The full per-record source list is available to authenticated callers.